Twin Securities »

Atrium Therapeutics shares owned by Twin Securities

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Twin Securities from 13F filings

Historical chart of Twin Securities investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Twin Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Twin Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $667k 50k 13.37

More positions owned by Twin Securities

Electronic Arts (EA)
Warner Bros Discovery Com Ser A (WBD)
Clearwater Analytics Hldgs I Cl A (CWAN)
Hologic
Kenvue (KVUE)
Revolution Medicines (RVMD)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
Apellis Pharmaceuticals (APLS)
Onestream Cl A
Take-Two Interactive Software (TTWO)
Day One Biopharmaceuticals I (DAWN)
Atrium Therapeutics (RNA)
Acuren Corporation (TIC)
Manchester Utd Ord Cl A (MANU)

View all positions for Twin Securities

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics